The US Food and Drug Administration (FDA) withdrew a proposed rule on label changes for generic drugs after concerns were raised and FDA resources were considered. Some expressed concern that temporary labeling differences between generic drugs and corresponding brand/trade name drugs could complicate healthcare decision making. Read more about this issue.
Are you interested in working with other quality professionals? If so, join the PAHQ Board. The following positions are available: Membership Chair (currently vacant) Market the organization to increase membership. Some type of marketing campaign to get membership up. Infuse the organization with entry level and mid-career quality professionals so that the organization has [...]
Learn more about 2018 ACT 112 - Patient Test Result Information Act Act of Oct. 24, 2018, P.L. 719, No. 112 Cl. 35 You can also read a joint letter to Rachel L. Levine, MD at the PA Department of Health from Hospital & Healthsystem Association of Pennsylvania (HAP) and PA Medical Society
Barbara Rebold attended the 2018 National Association for Healthcare Quality Next (NAHQ Next) conference in Minneapolis from November 4 to 7, 2018. The articles below summarize the lessons learned at the conference. Patient Safety Managing the Patient Safety "Other" Event Category: Phyllis Ragland, RN, CPHQ, CPPS, a Clinical Patient Safety Adviser from American Data Network PSO presented [...]
© Copyright | Pennsylvania Association for Healthcare Quality | All Rights Reserved | Privacy Policy | Managers
